ASSOCIATION BETWEEN DENGUE VIRUS RELATED COMPLICATIONS AND PATIENTS’ DEMOGRAPHIC AND CLINICAL CHARACTERISTICS
Article Sidebar
Main Article Content
Abstract
OBJECTIVE: To explore the association between observed complications in patients diagnosed with dengue fever and patients’ demographic and clinical characteristics.
METHODS: This cross-sectional analysis of data collected from prospective study conducted in a private hospital in Peshawar, Pakistan and comprised data of dengue patients admitted from June 2018 to December 2019. Laboratory parameters and clinical outcomes were studied. STATA 16 was used for data management and analysis.
RESULTS: Out of 200 diagnosed patients of Dengue fever, 135 (67.5%) were males and 65 (32.5%) were females. The median age of diagnosis was 36 years and 67.5% were males. Only 6 (3.0%) patients were diagnosed with severe dengue disease. Forty-two (29.0%) patients experienced one or more complication(s). Most common complications observed were coagulopathy (n=16; 8%), dengue shock syndrome (n=15; 7.5%) and sepsis with infection (n=6; 3%). Median (interquartile range-IQR) of platelet count (x10^12/l) was 72.9 (41.1-129.9) and 144.0 (100.4-205.0) in patients with and without complications respectively (p<0.001). Platelet transfusion was done in 27 (13.5%) and folic acid supplementation was given to 171 (85.5%) patients. Median (IQR) duration of hospital stay was 4 (3–6) and 3(2–4) days in patient with and without complications (<0.001). Overall mortality rate was 2.0% (n=4/200). There was a statistical difference in proportion of platelet transfusion, duration of hospital stay (number of day) and survival between those who had complications and those who didn’t (p=<0.001).
CONCLUSION: Platelet transfusion and duration of hospital stay in the hospital were significantly associated with higher risk of dengue complications.
Article Details
Work published in KMUJ is licensed under a
Creative Commons Attribution 4.0 License
Authors are permitted and encouraged to post their work online
(e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
References
Guha-Sapir D, Schimmer B. Dengue fever: new paradigms for a changing epidemiology. Emerg Themes Epidemiol 2005;2(1):1. https://doi.org/10.1186/1742-7622-2-1.
Khan E, Kisat M, Khan N, Nasir A, Ayub S, Hasan R. Demographic and Clinical Features of Dengue Fever in Pakistan from 2003–2007: A Retrospective Cross-Sectional Study. PLoS One 2010;5(9):e12505. https://doi.org/10.1371/journal.pone.0012505
Jahan F. Dengue Fever (DF) in Pakistan. Asia Pac Fam Med 2011;10(1):1. https://doi.org/10.1186/1447-056x-10-1
Melo CFOR, Delafiori J, Dabaja MZ, de Oliveira DN, Guerreiro TM, Colombo TE, et al. The role of lipids in the inception, maintenance and complications of dengue virus infection. Sci Rep 2018;8(1):11826. https://doi.org/10.1038/s41598-018-30385-x
Shastri PS, Gupta P, Kumar R. A prospective 3 year study of clinical spectrum and outcome of dengue fever in ICU from a tertiary care hospital in North India. Indian J Anaesth 2020;64(3):181-6. https://doi.org/10.4103/ija.ija_865_19
Khetarpal N, Khanna I. Dengue fever: causes, complications, and vaccine strategies. J Immunol Res 2016;2016:6803098. https://doi.org/10.1155/2016/6803098.
Carod-Artal FJ, Wichmann O, Farrar J, Gascón J. Neurological complications of dengue virus infection. Lancet Neurol 2013;12(9):906-19. https://doi.org/10.1016/s1474-4422(13)70150-9
Khan J, Ghaffar A, Khan SA. The changing epidemiological pattern of Dengue in Swat, Khyber Pakhtunkhwa. PLoS One. 2018 Apr 24;13(4):e0195706. https://doi.org/10.1371/journal.pone.0195706. Erratum in: PLoS One. 2018 Sep 17;13(9):e0204465. https://doi.org/10.1371/journal.pone.0204465
Mohamud MA, Qazi U, Latif A, Khan IU, Anwar S. Dengue outbreak response and control in Khyber Pakhtunkhwa, Pakistan: A Mixed Methods Study. J Epidemiol Glob Health. 2020 Mar;10(1):74-81. https://10.2991/jegh.k.191125.001.
Ahmed MS, Zeb R, Zeb J, Khan A, Khan Y. Outcome of dengue fever admitted at district head quarter hospital Kohat, Pakistan during 2015-16. Rawal Med J 2018; 43(3): 377-380.
Hu D, Di B, Ding X, Wang Y, Chen Y, Pan Y, et al. Kinetics of non-structural protein 1, IgM and IgG antibodies in dengue type 1 primary infection. Virol J 2011;8:47. https://doi.org/10.1186/1743-422x-8-47
Tristão-Sá R, Kubelka CF, Zandonade E, Zagne SMO, Rocha N de SM, Zagne LO, et al. Clinical and hepatic evaluation in adult dengue patients: a prospective two-month cohort study. Rev Soc Bras Med Trop 2012;45(6):675-81. https://doi.org/10.1590/s0037-86822012000600004
Namvongsa V, Sirivichayakul C, Songsithichok S, Chanthavanich P, Chokejindachai W, Sitcharungsi R. Differences in clinical features between children and adults with dengue hemorrhagic fever/dengue shock syndrome. Southeast Asian J Trop Med Public Health 2013;44(5):772-9.
Alves MJ, Fernandes PL, Amaro F, Osório H, Luz T, Parreira P, et al. Clinical presentation and laboratory findings for the first autochthonous cases of dengue fever in Madeira island, Portugal, October 2012. Euro Surveill 2013;18:20398.
Puccioni-Sohler M, Rosadas C, Cabral-Castro MJ. Neurological complications in dengue infection: a review for clinical practice. Arq Neuropsiquiatr 2013;71(9B):667-71. https://doi.org/10.1590/0004-282x20130147
Verma R, Sharma P, Garg RK, Atam V, Singh MK, Mehrotra HS. Neurological complications of dengue fever: Experience from a tertiary center of north India. Ann Indian Acad Neurol 2011;14(4):272-8. https://doi.org/10.4103/0972-2327.91946
Kamath SR, Ranjit S. Clinical features, complications and atypical manifestations of children with severe forms of dengue hemorrhagic fever in South India. Indian J Pediatr 2006;73:889-95. https://doi.org/10.1007/bf02859281
Roy A, Sarkar D, Chakraborty S, Chaudhuri J, Ghosh P, Chakraborty S. Profile of hepatic involvement by dengue virus in dengue infected children. N Am J Med Sci 2013;5(8):480-5. https://doi.org/10.4103/1947-2714.117313
Larreal Y, Valero N, Estévez J, Reyes I, Maldonado M, Espina LM, et al. Hepatic alterations in patients with dengue. Invest Clin 2005;46(2):169-78.
Hien TT, Vinh NN, Hien PTD, Chinh NT, Simmons C, Wills B, et al. Liver involvement associated with dengue infection in adults in Vietnam. Am J Trop Med Hyg 2010;83(4):774-80. https://doi.org/10.4269/ajtmh.2010.10-0090
Iqtadar S, Akbar N, Huma N, Randhawa FA. Profile of hepatic involvement in dengue infections in adult Pakistani population. Pak J Med Sci 2017;33(4):963-7. https://doi.org/10.12669/pjms.334.13026
Davis JS, Bourke P. Rhabdomyolysis Associated with Dengue Virus Infection. Clin Infect Dis 2004;38(10):e109-11. https://doi.org/10.1086/392510
Makroo RN, Raina V, Kumar P, Kanth RK. Role of platelet transfusion in the management of dengue patients in a tertiary care hospital. Asian J Transfus Sci 2007;1(1):4-7. https://doi.org/10.4103/0973-6247.28065
Kumar ND, Tomar V, Singh B, Kela K. Platelet transfusion practice during dengue fever epidemic. Indian J Pathol Microbiol 2000;43(1):55-60.
Pothapregada S, Kamalakannan B, Thulasingam M. Role of platelet transfusion in children with bleeding in dengue fever. J Vector Borne Dis 2015;52(4):304-8.
Pooransingh S, Teelucksingh S, Dialsingh I. Dengue deaths: associated factors and length of hospital stay. Adv Prev Med 2016;2016:6807674. https://doi.org/10.1155/2016/6807674
Jayanthi HK, Tulasi SK. Correlation study between platelet count, leukocyte count, nonhemorrhagic complications, and duration of hospital stay in dengue fever with thrombocytopenia. J Fam Med Prim Care 2016;5(1):120-3. https://doi.org/10.4103/2249-4863.184635